“Many experts fear that policymakers are underestimating the risk of corruption in NHI.” – Editorial Business Day (6 March 2026)
“Writing in the SA Medical Journal, N Mofolo and C Heunis present a critical analysis of five major constitutional violations, multi-departmental co-ordination failures and financial sustainability concerns that they believe threaten the NHI’s transformative potential. – MedicalBrief (4 March 2026) “Health workforce policies were misaligned with NHI requirements even during preparatory phases. Such policy incoherence is inevitable given absent enabling organisational frameworks.”
The JSE-listed healthcare investment holding company AfroCentric Investment Corporation reported a sharp rise in revenue for the year to end-December, despite a loss of R1.27bn (151.55 cents per share). – Business Day (5 March 2026). “Total revenue from continuing operations climbed by 93.9% to R7.30bn. This compares with R3.76bn in the previous six-month period. Headline earnings improved to R117.1m, or 13.92 cents per share, up from R31.9m. “AfroCentric runs a diversified healthcare portfolio. Its best-known assets include Medscheme and Pharmacy Direct, a specialist medicine provider. Sanlam now holds a 59% stake in AfroCentric.”
Health Minister Aaron Motsoaledi told Parliament that the Health Department will press ahead with NHI preparations, despite a recent High Court order to pause any immediate proclamation or implementation of sections of the NHI Act, reported Business Day 5 March 2026